Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Gerui Pharmaceutical is a comprehensive pharmaceutical enterprise located in the Shijiazhuang High-tech Industrial Development Zone, Hebei Province, China. Founded in 1998, the company specializes in the research, development, production, and marketing of chemical active pharmaceutical ingredients (APIs) and finished drug preparations. Its core therapeutic focus includes cardiovascular health, endocrinology, and anti-infectives, with a strong emphasis on high-quality generic drug production. The company maintains multiple GMP-certified production lines for oral solid dosages, including tablets and capsules. Shijiazhuang Gerui Pharmaceutical serves the Chinese domestic market and has established an international presence through the export of its pharmaceutical products. The company is a key player in the regional pharmaceutical cluster of Shijiazhuang, often referred to as China's Medicine Capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 石家庄格瑞药业.